semaglutide similar drugs Comparing Ozempic, Wegovy and Other GLP-1 FDA warns about compounded versions

Elevated glutamate levels in the basal ganglia, an area of the brain devoted to motor control, motivation, and decision making, was found to be associated with depressed patients who also have systemic inflammation (Neuroscience Online)

While combination therapy with metformin and GLP-1 drugs is evidence-based for many patients, genetic variants in GLP-1 receptor signaling and related pathways may help provide context for how your body utilizes these medications, supporting a more personalized conversation with your healthcare provider

Body composition research One of the most important questions in obesity pharmacotherapy is whether weight loss preserves or degrades lean body mass

This is the first large-scale, real-world body-composition comparison of the two market-leading GLP-1 drugs outside the trial environment and it tilts the muscle-preservation question more sharply toward semaglutide than the SURMOUNT and STEP DXA substudies suggested